All conditions
Medical condition
Benign Prostatic Hyperplasia
Also known as: BPH · Enlarged Prostate
Benign prostatic hyperplasia is non-malignant enlargement of the prostate causing lower urinary tract symptoms (LUTS). DHT is a primary driver; PSA monitoring is standard.
Last reviewed
Overview
What you need to know
Provider-reviewed assessment uses symptom indexing, PSA, and DHT context. oMeds surfaces biomarker flags relevant to candidacy for 5α-reductase inhibition and integrates urology referral for moderate-to-severe LUTS or PSA abnormalities.
Knowledge graph
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.